Skip to main content

Table 3 Comparison of demographic and pathological characteristics between patients with and without atrial fibrillation events

From: Detection of arrhythmia using an implantable cardiac monitor following a cryptogenic stroke: a single-center observational study

Parameter No atrial fibrillation n = 69 Atrial fibrillation n = 19 P-value
Age (years), median (range) 64 (30–89) 74 (47–83) 0.060
Gender, n (%)    0.377
 Male 44 (63.8) 10 (52.6)  
 Female 25 (36.2) 9 (47.4)  
Event, n (%)    0.512
 Stroke 62 (89.9) 18 (94.7)  
 Transient ischemic attack 7 (10.1) 1 (5.3)  
 Body mass index (kg/m2), median (range) 27 (19–49) 28 (23–44) 0.478
Comorbidity, n (%)
 Hypertension 47 (68.1) 12 (63.2) 0.684
 Diabetes mellitus 17 (24.6) 3 (15.8) 0.415
 Vasculopathy 16 (23.2) 3 (15.8) 0.488
 Heart failure 3 (4.3) 0 0.355
CHA2DS2-VASc score, median (range) 4 (2–7) 5 (2–7) 0.346
 Score 2, n (%) 6 (8.7) 1 (5.3)  
 Score 3, n (%) 16 (23.2) 4 (21.1)  
 Score 4, n (%) 16 (23.2) 3 (15.8)  
 Score 5, n (%) 17 (24.6) 5 (26.3)  
 Score 6, n (%) 7 (10.1) 4 (21.1)  
 Score 7, n (%) 7 (10.1) 2 (10.5)  
Extrasystole, n (%) 52 (75.4) 12 (63.2) 0.290
Number of drugs, median (range) 4 (1–14) 5 (2–8) 0.992
Smocking status, n (%)    0.720
 Nonsmoker 37 (53.6) 12 (63.2)  
 Smoker 21 (30.4) 4 (21.1)  
 Ex-smoker 9 (13.0) 3 (15.8)  
 No indication 2 (2.9) 0  
Observation period (months), median (range) 23 (1–33) 7 (1–32) 0.002
Recurrent stroke during observation period, n (%) XX XX XX
  1. Significant P-value is in itlaics